Literature DB >> 28910989

Dystonia.

Eduardo De Pablo-Fernandez1,2, Thomas T Warner1,2.   

Abstract

Introduction: Dystonia is a clinically heterogeneous group of hyperkinetic movement disorders. Recent advances have provided a better understanding of these conditions with significant clinical impact. Sources of data: Peer reviewed journals and reviews. PubMed.gov. Areas of agreement: A recent consensus classification, including the assessment of phenomenology and identification of the dystonia syndromes, has provided a helpful tool for the clinical assessment. New forms of monogenic dystonia have been recently identified. Areas of controversy: Despite recent advances in the understanding of dystonia, treatment remains symptomatic in most patients. Growing points: Recent advances in genetics have provided a better understanding of the potential pathogenic mechanisms involved in dystonia. Deep brain stimulation has shown to improve focal and combined forms of dystonia and its indications are constantly expanding. Areas timely for developing research: Growing understanding of the disease mechanisms involved will allow the development of targeted and disease-modifying therapies in the future.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  botulinum toxin; dystonia

Mesh:

Year:  2017        PMID: 28910989     DOI: 10.1093/bmb/ldx019

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  2 in total

1.  Clinical Observation of Botulinum Toxin Injection in the Treatment of Focal Dystonia and Muscle Spasm.

Authors:  Zhen Zhang
Journal:  Biomed Res Int       Date:  2022-09-05       Impact factor: 3.246

2.  A survey of lifestyle factors in dystonia.

Authors:  Jacob Söderlund; Dag Nyholm
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.